{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:27:05Z","timestamp":1780316825642,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.endinu.2017.09.006","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T11:03:55Z","timestamp":1511262235000},"page":"52-59","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Revisi\u00f3n del complejo de Carney: Aspectos gen\u00e9ticos"],"prefix":"10.1016","volume":"65","author":[{"given":"Mar\u00eda Bel\u00e9n","family":"Bosco Schamun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Graffigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"de Miguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fainstein Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.endinu.2017.09.006_bib0255","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)."},{"key":"10.1016\/j.endinu.2017.09.006_bib0260","first-page":"1","article-title":"The discovery of the Carney complex","volume":"5","author":"Carney","year":"2010","journal-title":"Endocrinology News from Mayo Clinic"},{"key":"10.1016\/j.endinu.2017.09.006_bib0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000095527","article-title":"Carney complex: Pathology and molecular genetics","volume":"83","author":"Boikos","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.endinu.2017.09.006_bib0270","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Genetics of endocrine disease. Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endinu.2017.09.006_bib0275","unstructured":"Stratakis CA, Salpea P, Raygada M. Carney Complex. Gene Reviews NCBI Bookshelf. Seattle (WA): University of Washington, Seattle; 2015; p. 1-17 [consulta 1 May 2017]. Disponible en: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1286\/"},{"key":"10.1016\/j.endinu.2017.09.006_bib0280","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5\u2032-monophosphate-dependent protein kinase (PRKAR1A): Phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endinu.2017.09.006_bib0285","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.endonu.2011.03.001","article-title":"Complejo de Carney","volume":"58","author":"Losada Grande","year":"2011","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.endinu.2017.09.006_bib0290","series-title":"Endocrinology adult and pediatric: The adrenal gland","first-page":"e81","article-title":"Adrenal causes of hypercortisolism","author":"Jameson","year":"2013"},{"key":"10.1016\/j.endinu.2017.09.006_bib0295","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1530\/EJE-15-0209","article-title":"Carney complex: An update","volume":"173","author":"Correa","year":"2015","journal-title":"Eur J Endocrinol."},{"key":"10.1016\/j.endinu.2017.09.006_bib0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00019616-199201000-00003","article-title":"Primary pigmented nodular adrenocortical disease and its associated conditions","volume":"2","author":"Carney","year":"1992","journal-title":"Endocrinologist"},{"key":"10.1016\/j.endinu.2017.09.006_bib0305","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"2","author":"Kirschner","year":"2000","journal-title":"Nat Genet."},{"key":"10.1016\/j.endinu.2017.09.006_bib0310","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jmg.40.4.268","article-title":"Chromosome 2 (2p16) abnormalities in Carney complex tumours","volume":"40","author":"Matyakhina","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.endinu.2017.09.006_bib0315","series-title":"Introducci\u00f3n a la Biolog\u00eda Celular","first-page":"900","author":"Alberts","year":"2011"},{"key":"10.1016\/j.endinu.2017.09.006_bib0320","series-title":"Biolog\u00eda celular y molecular","first-page":"1186","author":"Lodish","year":"2016"},{"key":"10.1016\/j.endinu.2017.09.006_bib0325","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ejhg.2008.85","article-title":"A cAMP-specific phosphodiesterase (PDE8B) that is mutated in adrenal hyperplasia is expressed widely in human and mouse tissues: A novel PDE8B isoform in human adrenal cortex","volume":"16","author":"Horvath","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.endinu.2017.09.006_bib0330","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/mol.110.069104","article-title":"The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland","volume":"79","author":"Tsai L-CL","year":"2011","journal-title":"Mol Pharmacol."},{"key":"10.1016\/j.endinu.2017.09.006_bib0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0163-7258(91)90075-W","article-title":"Cyclic nucleotide-dependent protein kinases","volume":"50","author":"Scott","year":"1991","journal-title":"Pharmacol Ther."},{"key":"10.1016\/j.endinu.2017.09.006_bib0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/1040-8428(94)00166-9","article-title":"cAMP-dependent protein kinase: Role in normal and malignant growth","volume":"21","author":"Cho-Chung","year":"1995","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1016\/j.endinu.2017.09.006_bib0345","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.molcel.2006.09.015","article-title":"A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase","volume":"24","author":"Kinderman","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.endinu.2017.09.006_bib0350","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1210\/en.2004-0900","article-title":"Minireview: PRKAR1A: Normal and abnormal functions","volume":"145","author":"Bossis","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.endinu.2017.09.006_bib0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1040-7952(97)80019-5","article-title":"Structure, function, and regulation of human cAMP-dependent protein kinases","volume":"31","author":"Tasken","year":"1997","journal-title":"Adv Second Messenger Phosphoprot Res"},{"key":"10.1016\/j.endinu.2017.09.006_bib0360","unstructured":"Stratakis CA. Update on genomics in pediatric endocrinology. En: The Endocrine Society's 98th Annual Meeting&Expo. Genetic defects affecting adrenal development in humans and mice: Lessons from cAMP signaling and related pathways. Boston, USA; 2016."},{"key":"10.1016\/j.endinu.2017.09.006_bib0365","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/CCO.0b013e32801195eb","article-title":"Carney complex: The first 20 years","volume":"19","author":"Boikos","year":"2007","journal-title":"Curr Opin.Oncol"},{"key":"10.1016\/j.endinu.2017.09.006_bib0370","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/humu.21178","article-title":"Mutations and polymorphisms in the gene encoding regulatory subunit type 1-alpha of protein kinase a (PRKAR1A): An update","volume":"31","author":"Horvath","year":"2010","journal-title":"Hum Mutat."},{"key":"10.1016\/j.endinu.2017.09.006_bib0375","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.1213979","article-title":"Structure and allostery of the PKA RII\u03b2 tetrameric holoenzyme","volume":"335","author":"Zhang","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.endinu.2017.09.006_bib0380","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2006-0188","article-title":"PRKAR1A mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex","volume":"91","author":"Robinson-White","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.09.006_bib0385","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1074\/jbc.272.7.3993","article-title":"Compensatory regulation of RI alpha protein levels in protein kinase A mutant mice","volume":"272","author":"Amieux","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.endinu.2017.09.006_bib0390","doi-asserted-by":"crossref","first-page":"8811","DOI":"10.1158\/0008-5472.CAN-04-3620","article-title":"Down-regulation of regulatory subunit type 1A of protein kinase A leads to endocrine and other tumors","volume":"64","author":"Griffin","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.endinu.2017.09.006_bib0395","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1590\/S0004-27302007000800009","article-title":"Primary pigmented nodular adrenocortical disease and Cushing's syndrome","volume":"51","author":"Horvath","year":"2007","journal-title":"Arq Bras Endocrinol Metabol."},{"key":"10.1016\/j.endinu.2017.09.006_bib0400","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endinu.2017.09.006_bib0405","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1210\/jc.2014-3295","article-title":"E pluribus unum? The main protein kinase a catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors","volume":"99","author":"Stratakis","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.09.006_bib0410","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.beem.2010.10.006","article-title":"Carney complex and other conditions associated with micronodular adrenal hyperplasias","volume":"24","author":"Almeida","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"10.1016\/j.endinu.2017.09.006_bib0415","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/(SICI)1096-8628(19981102)80:2<183::AID-AJMG19>3.0.CO;2-I","article-title":"Carney complex: Diagnosis and management of the complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas","volume":"80","author":"Stratakis","year":"1998","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.endinu.2017.09.006_bib0420","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endinu.2017.09.006_bib0425","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-006-0265-2","article-title":"Pituitary pathology in patients with Carney complex: Growth-hormone producing hyperplasia or tumors and their association with other abnormalities","volume":"9","author":"Boikos","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.09.006_bib0430","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/js.2017-00231","article-title":"Corticotropinoma as a component of Carney complex","volume":"1","author":"Hern\u00e1ndez-Ram\u00edrez","year":"2017","journal-title":"J Endocr Soc."},{"key":"10.1016\/j.endinu.2017.09.006_bib0435","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nsmb.1550","article-title":"Nonsense-mediated mRNA decay (NMD) mechanisms","volume":"16","author":"Brogna","year":"2009","journal-title":"Nat Struct Mol Biol."},{"key":"10.1016\/j.endinu.2017.09.006_bib0440","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/humu.20688","article-title":"In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay","volume":"29","author":"Greene","year":"2008","journal-title":"Hum Mutat."},{"key":"10.1016\/j.endinu.2017.09.006_bib0445","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1096-7192(03)00006-4","article-title":"Clinical and molecular genetics of Carney complex","volume":"78","author":"Sandrini","year":"2003","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.endinu.2017.09.006_bib0450","first-page":"99","article-title":"Deletions of the PRKAR1A locus at 17q24.2-q24.3 in carney complex: Genotype-phenotype correlations and implications for genetic testing","author":"Salpea","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endinu.2017.09.006_bib0455","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Lib\u00e9","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.endinu.2017.09.006_bib0460","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jc.2010-1704","article-title":"Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype","volume":"96","author":"Lib\u00e9","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.endinu.2017.09.006_bib0465","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2008-1076694","article-title":"Phosphodiesterase 11A expression in the adrenal cortex, primary pigmented nodular adrenocortical disease, and other corticotropin-independent lesions","volume":"40","author":"Boikos","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.endinu.2017.09.006_bib0470","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterase: Molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.endinu.2017.09.006_bib0475","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1369\/jhc.5A6625.2005","article-title":"Expression of PDE11A in normal and malignant human tissues","volume":"53","author":"D\u2019Andrea","year":"2005","journal-title":"J Histochem Cytochem."},{"key":"10.1016\/j.endinu.2017.09.006_bib0480","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.endinu.2017.09.006_bib0485","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-006-0266-1","article-title":"PRKAR1A mutations in primary pigmented nodular adrenocortical disease","volume":"9","author":"Cazabat","year":"2006","journal-title":"Pituitary"},{"key":"10.1016\/j.endinu.2017.09.006_bib0490","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3389\/fcell.2015.00026","article-title":"PRKACA: The catalytic subunit of protein kinase A and adrenocortical tumors","volume":"3","author":"Berthon","year":"2015","journal-title":"Front cell Dev Biol"},{"key":"10.1016\/j.endinu.2017.09.006_bib0495","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: Molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.endinu.2017.09.006_bib0500","first-page":"1067","article-title":"PRKACB and Carney complex","author":"Forlino","year":"2014","journal-title":"N Engl J Med."}],"container-title":["Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417302379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2530016417302379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,6]],"date-time":"2019-10-06T11:39:19Z","timestamp":1570361959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2530016417302379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2530016417302379"],"URL":"https:\/\/doi.org\/10.1016\/j.endinu.2017.09.006","relation":{},"ISSN":["2530-0164"],"issn-type":[{"value":"2530-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisi\u00f3n del complejo de Carney: Aspectos gen\u00e9ticos","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda, Diabetes y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endinu.2017.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 SEEN y SED. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}